Pharmaceuticals

Pharmaceuticals

10,000 healthcare mergers

3M sells pharma unit

Astra Zeneca buys MedImmune

Aventis/Sanofi

Aventis/Sanofi merger

Bayer/Schering/Merck

Big pharma sits at the table

Big pharma writes the regs

Big pharma and homeland profits

Big pharma's crisis

Bristol Myers Squibb sells off OTC drugs

Conflict of interest and regulation

Drug innovation

Drug innovation stalled (2005)

Drugstore matrix shift

Eli Lilly and blockbusters

FDA: Pharma's inside man

Generic drug consolidation more

Generic drug leaders, US

Glaxo, mergers, and innovation

Glaxo's deal with Synta

Great expectations, not so great results

Innovation, desperate for

Insurers versus drug companies

Japanese pharmaceutical concentration

Johnson & Johnson

Johnson & Johnson buys Pfizer's non-prescription products

Kyowa HAkiko bought by brewer Kirin

Medicare windfall

Merck and others buy startups

More pharmaceutical mergers?

Mylan/King merger it's off

Mylan/Merck (German)

Novartis/Chiron

Novartis competing against itself?

Novartis/Durascan

Novartis/Hexal + Novartis/Eon Labs

PBMe ve. Pharmacies

Pfizer and the advantages of being big

Pfizer/Esperion

Pfizer/Pharmacia

Pharmaceutical mergers

Pharmaceuticals and blockbusters

Pharmaceutical industry profile

Pharmacy benefit managers

Rite+Aid buys Eckerd

UCB/Celltech merger

UCB drops chemicals, Cyrtec picks them up